Expression of the tumor suppressor gene hypermethylated in cancer 1 in laryngeal carcinoma

Markowski,Jarosław; Sieroń,Aleksander  L.; Kasperczyk,Katarzyna; Ciupińska‑Kajor,Monika; Auguściak‑Duma,Aleksandra; Likus,Wirginia

doi:10.3892/ol.2015.2983

Expression of the tumor suppressor gene hypermethylated in cancer 1 in laryngeal carcinoma

Authors:
- Jarosław Markowski
- Aleksander L. Sieroń
- Katarzyna Kasperczyk
- Monika Ciupińska‑Kajor
- Aleksandra Auguściak‑Duma
- Wirginia Likus
View Affiliations

Affiliations: Department of Laryngology, School of Medicine in Katowice, Medical University of Silesia, Katowice 40-027, Poland, Department of Molecular Biology and Genetics, School of Medicine in Katowice, Medical University of Silesia, Katowice 40-752, Poland, Department of Pathomorphology, School of Medicine in Katowice, Medical University of Silesia, Katowice 40-752, Poland, Department of Human Anatomy, School of Medicine in Katowice, Medical University of Silesia, Katowice 40-752, Poland
Published online on: February 25, 2015 https://doi.org/10.3892/ol.2015.2983
Pages: 2299-2302

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hypermethylated in cancer 1 (HIC1) is a putative suppressor gene, cooperating with TP53 in the regulation of apoptosis. The promoter site of this gene contains CpG islands susceptible to methylation. Altered methylation leads to the silencing of HIC1. Persistent loss of HIC1 function reflects the attenuation of proapoptotic characteristics of TP53 and may constitute the background for carcinogenesis. Altered methylation profiles along with diminished expression of HIC1 were documented in a number of solid neoplasms. The aim of this study was to evaluate the expression of the HIC1 gene in laryngeal carcinoma. RNA was extracted from samples of laryngeal cancer and corresponding healthy tissues of 21 patients with advanced laryngeal cancer (T3‑T4). The amount of RNA (cDNA) was evaluated using reverse transcription-quantitative polymerase chain reaction with GADPH as the reference gene. Data demonstrated that HIC1 expression was significantly reduced in laryngeal cancer tissues. The relative expression of HIC1 was found to be ~40% lower in tumor samples compared to that in healthy controls. The median tumor/normal tissue ratio for HIC1 was 0.615. These results suggest that low HIC1 expression may be associated with neoplastic transformation in the larynx.

View Figures

View References

1	The national cancer registry. http://onkologia.org.pl/[(In Polish)]. Accessed. March 15–2014.
2	Bień S, Kamiński B, Żyłka S, Meżyk R and Piasta Z: Evolution of the epidemiology and clinical characteristics of larynx and hypopharynx carcinoma in poland from 1991 to 2001. Eur Arch Otorhinolaryngol. 1:S39–S46. 2008. View Article : Google Scholar
3	Wu CT and Morris JR: Genes, genetics and epigenetics: a correspondence. Sciences. 293:1103–1105. 2001. View Article : Google Scholar
4	Wong TS, Gao W, Li ZH, Chan JY and Ho WK: Epigenetic dysregulation in laryngeal squamous cell carcinoma. J Oncol. 2012:7394612012. View Article : Google Scholar : PubMed/NCBI
5	Jabłońska J and Jesionek-Kupnicka D: Zmiany epigenetyczne w nowotworach. Onkol Pol. 7:181–185. 2004.[(In Polish)].
6	Severin PM, Zou X, Gaub HE and Schulten K: Cytosine methylation alters dna mechanical properties. Nucleic Acids Res. 39:8740–8751. 2011. View Article : Google Scholar : PubMed/NCBI
7	Baylin SB and Herman JG: Dna hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16:168–174. 2000. View Article : Google Scholar : PubMed/NCBI
8	Chang HW, Ling GS, Wei WI and Yuen AP: Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma. Cancer. 101:125–132. 2004. View Article : Google Scholar : PubMed/NCBI
9	van Engeland M, Weijenberg MP, Roemen GM, Brink M, de Bruïne AP, Goldbohm RA, van den Brandt PA, Baylin SB, de Goeij AF and Herman JG: Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the netherlands cohort study on diet and cancer. Cancer Res. 63:3133–3137. 2003.PubMed/NCBI
10	Fleuriel C, Touka M, Boulay G, Guérardel C, Rood BR and Leprince D: Hic1 (hypermethylated in cancer 1) epigenetic silencing in tumors. Int J Biochem Cell Biol. 41:26–33. 2009. View Article : Google Scholar : PubMed/NCBI
11	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
12	Peralta R, Valdivia A, Alvarado-Cabrero I, Gallegos F, Apresa T, Hernández D, Mendoza M, Romero P, Paniagua L, Ibáñez M, Cabrera L and Salcedo M: Correlation between expression of cellular retinol-binding protein 1 and its methylation status in larynx cancer. J Clin Pathol. 65:46–50. 2012. View Article : Google Scholar : PubMed/NCBI
13	Bazan V, Zanna I, Migliavacca M, Sanz-Casla MT, Maestro ML, Corsale S, Macaluso M, Dardanoni G, Restivo S, Quintela PL, Bernaldez R, Salerno S, Morello V, Tomasino RM, Gebbia N and Russo A: Prognostic significance of p16ink4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma. J Cell Physiol. 192:286–293. 2002. View Article : Google Scholar : PubMed/NCBI
14	Kong WJ, Zhang S, Guo C, Zhang S, Wang Y and Zhang D: Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Laryngoscope. 115:1395–1401. 2005. View Article : Google Scholar : PubMed/NCBI
15	Paluszczak J, Misiak P, Wierzbicka M, Woźniak A and Baer-Dubowska W: Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa. Oral Oncol. 47:104–107. 2011. View Article : Google Scholar : PubMed/NCBI
16	Wang J, Chen H, Fu S, Xu ZM, Sun KL and Fu WN: The involvement of chd5 hypermethylation in laryngeal squamous cell carcinoma. Oral Oncol. 47:601–608. 2011. View Article : Google Scholar : PubMed/NCBI
17	Smigiel R, Sasiadek M, Krecicki T, Ramsey D, Jagielski J and Blin N: Inactivation of the cyclin-dependent kinase inhibitor 2a (cdkn2a) gene in squamous cell carcinoma of the larynx. Mol Carcinog. 39:147–154. 2004. View Article : Google Scholar : PubMed/NCBI
18	Olasz J, Juhász A, Remenár E, Engi H, Bak M, Csuka O and Kásler M: Rar beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age. Oncol Rep. 18:105–112. 2007.PubMed/NCBI
19	Temam S, Bénard J, Dugas C, Trassard M, Gormally E, Soria JC, Faivre S, Luboinski B, Marandas P, Hainaut P, Lenoir G, Mao L and Janot F: Molecular detection of early-stage laryngopharyngeal squamous cell carcinomas. Clin Cancer Res. 11:2547–2551. 2005. View Article : Google Scholar : PubMed/NCBI
20	Chen WY, Wang DH, Yen RC, Luo J, Gu W and Baylin SB: Tumor suppressor hic1 directly regulates sirt1 to modulate p53-dependent dna-damage responses. Cell. 123:437–448. 2005. View Article : Google Scholar : PubMed/NCBI
21	Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R and Sinclair DA: Calorie restriction promotes mammalian cell survival by inducing the sirt1 deacetylase. Science. 305:390–392. 2004. View Article : Google Scholar : PubMed/NCBI
22	Vaquero A, Scher M, Erdjument-Bromage H, Tempst P, Serrano L and Reinberg D: Sirt1 regulates the histone methyl-transferase suv39h1 during heterochromatin formation. Nature. 450:440–444. 2007. View Article : Google Scholar : PubMed/NCBI
23	Kelly KF and Daniel JM: Poz for effect-poz-zf transcription factors in cancer and development. Trends Cell Biol. 16:578–587. 2006. View Article : Google Scholar : PubMed/NCBI
24	Briones VR, Chen S, Riegel AT and Lechleider RJ: Mechanism of fibroblast growth factor-binding protein 1 repression by tgf-beta. Biochem Biophys Res Commun. 345:595–601. 2006. View Article : Google Scholar : PubMed/NCBI
25	Tassi E, Henke RT, Bowden ET, Swift MR, Kodack DP, Kuo AH, Maitra A and Wellstein A: Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon. Cancer Res. 66:1191–1198. 2006. View Article : Google Scholar : PubMed/NCBI
26	Eguchi K, Kanai Y, Kobayashi K and Hirohashi S: Dna hypermethylation at the d17s5 locus in non-small cell lung cancers: its association with smoking history. Cancer Res. 57:4913–4915. 1997.PubMed/NCBI
27	Kanai Y, Hui AM, Sun L, Ushijima S, Sakamoto M, Tsuda H and Hirohashi S: Dna hypermethylation at the d17s5 locus and reduced hic-1 mrna expression are associated with hepatocarcinogenesis. Hepatology. 29:703–709. 1999. View Article : Google Scholar : PubMed/NCBI
28	Kanai YI, Ushijima S, Ochiai A, Eguchi K, Hui A and Hirohashi S: Dna hypermethylation at the d17s5 locus is associated with gastric carcinogenesis. Cancer Lett. 122:135–141. 1998. View Article : Google Scholar : PubMed/NCBI
29	Nicoll G, Crichton DN, McDowell HE, Kernohan N, Hupp TR and Thompson AM: Expression of the hypermethylated in cancer gene (hic-1) is associated with good outcome in human breast cancer. Br J Cancer. 85:1878–1882. 2001. View Article : Google Scholar : PubMed/NCBI
30	Hayashi M, Tokuchi Y, Hashimoto T, Hayashi S, Nishida K, Ishikawa Y, Nakagawa K, Tsuchiya S, Okumura S and Tsuchiya E: reduced hic-1 gene expression in non-small cell lung cancer and its clinical significance. Anticancer Res. 21:535–540. 2001.PubMed/NCBI
31	Brieger J, Mann SA, Pongsapich W, Koutsimpelas D, Fruth K and Mann WJ: Pharmacological genome demethylation increases radiosensitivity of head and neck squamous carcinoma cells. Int J Mol Med. 29:505–509. 2012.PubMed/NCBI
32	Zheng J, Wang J, Sun X, et al: HIC1 modulates prostate cancer progression by epigenetic modification. Clin Cancer Res. 19:1400–1410. 2013. View Article : Google Scholar : PubMed/NCBI
33	Stephen JK, Chen KM, Shah V, Havard S, Kapke A, Lu M, Benninger MS and Worsham MJ: Dna hypermethylation markers of poor outcome in laryngeal cancer. Clin Epigenetics. 1:61–69. 2010. View Article : Google Scholar : PubMed/NCBI